We help millions of women get a faster endometriosis diagnosis with our AI-augmented ultrasound software. Our solution provides every gynecologist with expert sonography skills.
Location: Switzerland
Total raised: $3.57M
Investors 1
| Date | Name | Website |
| 17.06.2024 | Venture Ki... | venturekic... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 15.07.2025 | Seed | $3.4M | Venture Ki... |
| 07.02.2025 | - | $165.41K | Venture Ki... |
Mentions in press and media 13
| Date | Title | Description |
| 15.07.2025 | Scanvio secures $3.4M to enable earlier diagnosis of endometriosis | Endometriosis often leads to prolonged pain, infertility, and a diminished quality of life, yet frequently remains undiagnosed for years due to the significant clinical expertise currently required for accurate detection. To address this c... |
| 09.07.2025 | Ten Medtech startups to explore US expansion opportunities | Following a competitive selection process that reviewed over 70 applications, a jury of investors and industry experts chose ten startups to join the upcoming roadshow in Boston—one of the world’s leading hubs for life sciences and healthc... |
| 15.05.2025 | Driving the ecosystem forward | Every year, the startup days are a great opportunity to take the pulse of the ecosystem. Start-ups at various stages of maturity are on site, as are investors and support organisations. Everyone agreed that these are not easy times for sta... |
| 08.02.2025 | Revolutionizing Endometriosis Diagnosis: Scanvio's Leap into AI-Driven Ultrasound | Endometriosis is a silent storm. It affects 10% of women globally, bringing chronic pain, excessive bleeding, and infertility. The economic toll? A staggering USD 12,970 per patient in healthcare costs and lost productivity. Yet, diagnosing... |
| 07.02.2025 | Scanvio gets CHF 150,000 from Venture Kick to democratize expert ultrasound | Endometriosis affects 10% of women worldwide, causing chronic pain, excessive bleeding, and unexplained infertility, with an estimated economic burden of USD 12,970 per patient in healthcare costs and workplace absences. Despite its prevale... |
| 07.02.2025 | CHF 150,000 from Venture Kick to democratize expert ultrasound | Endometriosis affects 10% of women worldwide, causing chronic pain, excessive bleeding, and unexplained infertility, with an estimated economic burden of USD 12,970 per patient in healthcare costs and workplace absences. Despite its preval... |
| 08.11.2024 | The Future of Innovation: How InnoBooster is Fueling Health and Environmental Solutions | In a world where challenges loom large, innovation is the beacon of hope. The InnoBooster program, powered by the Gebert Rüf Stiftung, is a launchpad for startups tackling pressing health and environmental issues. With CHF 150,000 in financ... |
| 05.11.2024 | InnoBooster startups address health and environmental issues | Powered by the Gebert Rüf Stiftung, the InnoBooster program aims to accelerate the market entry of promising university-based, high-potential business cases by providing financial support and resources. Eligible for the support are deeptec... |
| 15.07.2024 | CHF 40,000 for a minimally invasive diagnostic for sepsis, expert ultrasound access, and direct-to-consumer health risk assessment | EVIIVE: minimally invasive diagnostic for sepsis The current standard of care approach for sepsis is highly invasive, delayed, and insensitive. CEO Dr. Kevin Ho Wai Yim from UZH co-founded EVIIVE with CSO Dr. Richard Chahwan to provide a di... |
| 08.07.2024 | New portfolio companies for S2S Ventures | Designed for student entrepreneurs, S2S Ventures is an independent Students-2-Students venture capital fund offering CHF 25,000 in start-ups founded at Swiss institutions of higher education and provide them with personalized feedback and ... |
Show more